Arm Holdings has dropped 13% in a week amid hawkish Fed signals, but analysts remain split on whether the $342 price point is fair value or a setup for further pullback to $310.

What happened: Arm's stock fell 13.02% over the past week as the Federal Reserve signaled slower interest-rate cuts. The company reported that data center royalty revenue more than doubled year-over-year in Q4, and it disclosed more than $2 billion（約3200億円） in customer demand for its new Arm AGI CPU across FY2027 and FY2028, with Meta signed as lead co-development partner.

Why it matters: Arm is shifting from smartphone licensing fees to higher-margin data center chip royalties, a real business pivot. However, the stock now trades at a trailing P/E of 357x and forward P/E of 147x—multiples that have lapped the fundamentals. The fair-value question hinges on whether that $2 billion（約3200億円） AGI CPU pipeline converts into actual royalty revenue on schedule, which the next two quarterly reports will clarify.

What to watch: Of 40 covering analysts, 21 rate the stock Buy, 10 Hold, 7 Strong Buy, and 2 Sell. Consensus target is $254.87, implying roughly 25% downside from the current $342 level. Investors waiting for a pullback to the $310 zone on macro noise—rather than company-specific deterioration—could capture the multi-year AGI CPU thesis at a 10% better entry point with materially less drawdown risk.